高尿酸血癥患者血漿microRNA表達譜分析及其靶基因預(yù)測研究
發(fā)布時間：2018-08-03 13:11
【摘要】：目的:通過micro RNA基因芯片技術(shù)研究無癥狀高尿酸血癥患者與正常對照者血漿中micro RNA的表達差異,并對差異表達的micro RNA進行靶基因預(yù)測,探討micro RNA在高尿酸血癥中的作用機制。方法:1.選取4例無癥狀高尿酸血癥患者,4例正常對照者,取其外周血漿用Trizol法提取RNA,使用丹麥ExiqonTM公司的micro RNA芯片檢測其血漿中micro RNA表達譜,并篩選出顯著差異表達的micro RNA。2.選取1個顯著上調(diào)的micro RNA及2個顯著下調(diào)的micro RNA在50例無癥狀高尿酸血癥患者及50例正常對照者中,使用RT-PCR方法進行驗證。并對50例高尿酸血癥組及50例對照組進行相關(guān)臨床資料分析。3.通過搜索并匯總miranda數(shù)據(jù)庫、mirbase數(shù)據(jù)庫及targetcsan數(shù)據(jù)庫,對篩選出的差異表達的micro RNA進行靶基因預(yù)測,得到特異表達于外周血中的靶基因;再通過GO及Pathway分析,對預(yù)測出的靶基因進行相關(guān)分子功能分析。結(jié)果:1.micro RNA芯片表達結(jié)果顯示,共有263個micro RNA在高尿酸血癥組與對照組間表達有變化,其中差異表達顯著的共有11個,上調(diào)的有5個,下調(diào)的有6個。2.運用RT-PCR技術(shù),與對照組比較,高尿酸血癥組中mi R-519d-3p表達上調(diào),差異有統(tǒng)計學意義(P0.01);mi R-374a-5p、mi R-30c-5p表達下調(diào),差異有統(tǒng)計學意義(P0.01),驗證結(jié)果與micro RNA芯片結(jié)果一致。3.通過對顯著差異表達的micro RNA的靶基因預(yù)測及功能分析,發(fā)現(xiàn)這些異常表達的micro RNA主要通過其相關(guān)靶基因影響TGF-β信號通路、PI3K-Akt信號通路、細胞內(nèi)吞作用以及Notch信號通路等來發(fā)揮其作用。結(jié)論:micro RNA芯片技術(shù)是一種有效的高通量分析高尿酸血癥micro RNA表達譜的方法,相對于正常對照組,多種micro RNA在高尿酸血癥患者外周血漿中出現(xiàn)差異表達,有可能成為高尿酸血癥的新的分子生物學標志物并可能參與了高尿酸血癥的發(fā)病機制,但具體的分子機制還有待于進一步研究。
[Abstract]:Aim: to study the difference of micro RNA expression in plasma between asymptomatic hyperuricemia patients and normal controls by micro RNA gene chip technique, and to predict the target gene expression of micro RNA in order to explore the mechanism of micro RNA in hyperuricemia. Method 1: 1. Four patients with asymptomatic hyperuricemia and 4 normal controls were selected and their peripheral blood plasma was extracted by Trizol method. The expression profiles of micro RNA in plasma were detected by micro RNA microarray of ExiqonTM Company in Denmark, and the differentially expressed micro RNA.2was screened out. One significantly up-regulated micro RNA and two significantly down-regulated micro RNA were tested by RT-PCR in 50 asymptomatic hyperuricemia patients and 50 normal controls. The clinical data of 50 cases of hyperuricemia and 50 cases of control group were analyzed. By searching and summarizing miranda database and targetcsan database, the target gene of differentially expressed micro RNA was predicted, and then the target gene expressed in peripheral blood was obtained, and then analyzed by go and Pathway. The predicted target gene was analyzed by molecular function analysis. Results: 1. The results of RNA microarray showed that there were changes in the expression of 263 micro RNA between hyperuricemia group and control group, of which 11 were significantly different, 5 were up-regulated, and 6. 2 were down-regulated. Using RT-PCR technique, the expression of mi R-519d-3p was up-regulated in hyperuricemia group (P0.01), and the difference was statistically significant (P0.01). The difference was statistically significant (P0.01). The result was consistent with that of micro RNA chip. Through the prediction and functional analysis of the target genes of significantly differentially expressed micro RNA, it was found that the abnormal expression of micro RNA affected the PI3K-Akt signaling pathway mainly through its related target genes. Endocytosis and Notch signaling pathway play their roles. Conclusion the micro RNA microarray technique is an effective method for high-throughput analysis of micro RNA expression profiles in hyperuricemia patients. Compared with the control group, the differential expression of micro RNA was found in peripheral plasma of hyperuricemia patients. It may be a new molecular biomarker of hyperuricemia and may be involved in the pathogenesis of hyperuricemia, but the specific molecular mechanism remains to be further studied.
【學位授予單位】：青島大學
【學位級別】：博士
【學位授予年份】：2015
【分類號】：R589.7
[Abstract]:Aim: to study the difference of micro RNA expression in plasma between asymptomatic hyperuricemia patients and normal controls by micro RNA gene chip technique, and to predict the target gene expression of micro RNA in order to explore the mechanism of micro RNA in hyperuricemia. Method 1: 1. Four patients with asymptomatic hyperuricemia and 4 normal controls were selected and their peripheral blood plasma was extracted by Trizol method. The expression profiles of micro RNA in plasma were detected by micro RNA microarray of ExiqonTM Company in Denmark, and the differentially expressed micro RNA.2was screened out. One significantly up-regulated micro RNA and two significantly down-regulated micro RNA were tested by RT-PCR in 50 asymptomatic hyperuricemia patients and 50 normal controls. The clinical data of 50 cases of hyperuricemia and 50 cases of control group were analyzed. By searching and summarizing miranda database and targetcsan database, the target gene of differentially expressed micro RNA was predicted, and then the target gene expressed in peripheral blood was obtained, and then analyzed by go and Pathway. The predicted target gene was analyzed by molecular function analysis. Results: 1. The results of RNA microarray showed that there were changes in the expression of 263 micro RNA between hyperuricemia group and control group, of which 11 were significantly different, 5 were up-regulated, and 6. 2 were down-regulated. Using RT-PCR technique, the expression of mi R-519d-3p was up-regulated in hyperuricemia group (P0.01), and the difference was statistically significant (P0.01). The difference was statistically significant (P0.01). The result was consistent with that of micro RNA chip. Through the prediction and functional analysis of the target genes of significantly differentially expressed micro RNA, it was found that the abnormal expression of micro RNA affected the PI3K-Akt signaling pathway mainly through its related target genes. Endocytosis and Notch signaling pathway play their roles. Conclusion the micro RNA microarray technique is an effective method for high-throughput analysis of micro RNA expression profiles in hyperuricemia patients. Compared with the control group, the differential expression of micro RNA was found in peripheral plasma of hyperuricemia patients. It may be a new molecular biomarker of hyperuricemia and may be involved in the pathogenesis of hyperuricemia, but the specific molecular mechanism remains to be further studied.
【學位授予單位】：青島大學
【學位級別】：博士
【學位授予年份】：2015
【分類號】：R589.7
【相似文獻】
相關(guān)期刊論文 前10條
1 李黎;高尿酸血癥97例臨床分析[J];中國誤診學雜志;2005年14期
2 李曉君;;原發(fā)性擴張型心肌病伴高尿酸血癥1例[J];現(xiàn)代中西醫(yī)結(jié)合雜志;2006年02期
3 楊玉霞;劉勇;;高尿酸血癥綜合系統(tǒng)管理分析[J];臨床和實驗醫(yī)學雜志;2006年06期
4 李玉珍;張曉華;;89例中老年人高尿酸血癥臨床分析[J];河北醫(yī)藥;2006年12期
5 呂才模;彭潔敏;劉曉燕;翟蓓;丁春艷;;烏魯木齊市漢族健康體檢者高尿酸血癥調(diào)查分析[J];內(nèi)科;2009年06期
6 陳素芬;;高尿酸血癥患者疾病相關(guān)知識調(diào)查分析[J];護理管理雜志;2009年08期
7 楊聰;黃謙;馮國君;劉云祥;;西藏某地區(qū)體檢人群高尿酸血癥分析[J];西南國防醫(yī)藥;2010年02期
8 袁自宏;g，
本文編號：2161849
本文鏈接：http://sikaile.net/yixuelunwen/nfm/2161849.html
最近更新
教材專著
